Promis Neurosciences Inc (PMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 63,814 | 6,117 | 15,399 | 4,510 | 8,364 |
| Marketable Securities | 34 | 34 | 33 | 33 | 33 |
| TOTAL | $65,613 | $9,182 | $21,458 | $9,510 | $13,647 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 1,799 | 0 | 0 | 0 | 0 |
| TOTAL | $1,799 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $67,412 | $9,182 | $21,458 | $9,510 | $13,647 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,717 | 2,543 | 4,212 | 2,780 | 1,200 |
| Accrued Expenses | 4,898 | 7,868 | 8,000 | 7,044 | 2,856 |
| TOTAL | $6,615 | $10,412 | $12,211 | $9,824 | $4,056 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 79 | 29 | 60 | 68 | 119 |
| TOTAL | $79 | $29 | $60 | $68 | $119 |
| Total Liabilities | $6,694 | $10,441 | $12,271 | $9,892 | $4,175 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,968 | 8,968 | 2,152 | 2,072 | 1,308 |
| Retained earnings | -138,651 | -130,406 | -119,732 | -108,152 | -98,035 |
| Other shareholders' equity | -371 | -371 | -371 | -371 | -371 |
| TOTAL | $60,718 | $-1,259 | $9,187 | $-383 | $9,472 |
| Total Liabilities And Equity | $67,412 | $9,182 | $21,458 | $9,510 | $13,647 |